Medicare
- Report
The Budget and Economic Outlook: 2024 to 2034
In CBO’s projections, federal budget deficits total $20 trillion over the 2025–2034 period and federal debt held by the public reaches 116 percent of GDP. Economic growth slows to 1.5 percent in 2024 and then continues at a moderate pace.
- Report
Testimony on Federal Subsidies for Health Insurance and Policies to Reduce the Prices Paid by Commercial Insurers
Chapin White, CBO's Director of Health Analysis, testifies before the House Energy and Commerce Committee's Subcommittee on Health.
- Report
Additional Information About Drug Price Negotiation and CBO’s Simulation Model of Drug Development
In response to a request from Budget Committee Chairman Jodey Arrington and Congressman Michael C. Burgess, CBO provides information about its analysis of federal policies that affect the development of new drugs in the United States.
- Cost Estimate
Estimated Direct Spending and Revenue Effects of H.R. 5378, the Lower Costs, More Transparency Act
As posted on the website of the Clerk of the House on December 5, 2023
https://tinyurl.com/h2vpjp8a - Cost Estimate
Estimated Budgetary Effects of the Better Mental Health Care, Lower-Cost Drugs, and Extenders Act and Certain Provisions of the Modernizing and Ensuring PBM Accountability (MEPA) Act
As posted on the website of the Senate Committee on Finance on November 6, 2023
- Report
Answers to Questions for the Record Following a Hearing on Alternative Payment Models and the Slowdown in Federal Health Care Spending
The Senate Committee on the Budget convened a hearing at which Chapin White, CBO’s Director of Health Analysis, testified. This document provides CBO’s answers to questions submitted for the record.
- Presentation
Health Care and the Federal Budget
Presentation by Chapin White, CBO’s Director of Health Analysis, to the MITRE Health Advisory Council.
- Report
Testimony on Alternative Payment Models and the Slowdown in Federal Health Care Spending
CBO’s Director of Health Analysis, Chapin White, testifies on alternative payment models and the slowdown in federal health care spending.
- Blog Post
A Call for New Research in the Area of Obesity
To enhance its work for the Congress, CBO is looking for new research on factors that affect the use of anti-obesity medications and the impact of that use on other health care spending.
- Report
Federal Budgetary Effects of the Activities of the Center for Medicare & Medicaid Innovation
CBO estimates that the Center for Medicare & Medicaid Innovation’s (CMMI’s) activities increased federal spending between 2011 and 2020 and will also increase it from 2021 to 2030. In 2010, CBO projected that CMMI would produce savings.